Concepedia

Bin Zou

BZ

Statistics

Publications

44

Citations

4.4K

H-Index

26

Active since

2002

Affiliations

Novartis (Singapore)(Current)

Novartis (Switzerland)

Shanghai University of Traditional Chinese Medicine

Shuguang Hospital

Agency for Science, Technology and Research

Bin Zou is an author at Novartis (Singapore) specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

2002–2024

44

Publications

44

Spiroindolones, a Potent Compound Class for the Treatment of Malaria

Matthias Rottmann, Case W. McNamara, Bryan K. S. Yeung et al. · Science · 2010 · 1.2K citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study

Guoping Zheng, Lan-Fang Huang, Haijiang Tong et al. · Respiratory Research · 2014 · 460 citations · Full text

Medicine, Immunology, Pharmacology +17

Spirotetrahydro β-Carbolines (Spiroindolones): A New Class of Potent and Orally Efficacious Compounds for the Treatment of Malaria

Bryan K. S. Yeung, Bin Zou, Matthias Rottmann et al. · Journal of Medicinal Chemistry · 2010 · 425 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

Miguel Regueiro, Brian G. Feagan, Bin Zou et al. · Gastroenterology · 2016 · 329 citations · Full text

Medicine, Clinical Sciences, Surgery +14

A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis

Ujjini H. Manjunatha, Sumiti Vinayak, Jennifer A. Zambriski et al. · Nature · 2017 · 200 citations · Full text

Veterinary Medicine, Infectious Diseases, Medicinal Chemistry +9

1–5 of 44